J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malone, R. P.
Right arrow Articles by Cater, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malone, R. P.
Right arrow Articles by Cater, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

PEDIATRICS

Impersistence of Depression in Youth: Implications for Drug Study Design

Richard P. Malone, MD, David S. Bennett, PhD, Mary Anne Delaney, MD, Muniya S. Choudhury, PhD, James F. Luebbert, MD and Jacqueline Cater, PhD

From the Department of Psychiatry at Drexel University College of Medicine and Philadelphia Health & Education Corporation, Philadelphia, Pennsylvania (Dr Malone, Dr Bennett, Dr Delaney); Columbia University, New York, New York (Dr Choudhury); Wordsworth Academy in Ft. Washington, Pennsylvania (Dr Luebbert); and Biomedical Statistical Consulting, Wynnewood, Pennsylvania (Dr Cater).

Food and Drug Administration data show that most anti-depressant studies in youth do not show drug effect. The few positive studies used rigorous diagnostic screening procedures, suggesting major depressive disorder (MDD) may not be a persistent condition in a subgroup of youth. To investigate persistence of MDD, we serially assessed a cohort of inpatients admitted to the hospital with a clinical diagnosis of MDD. Assessments included a structured diagnostic interview, the Diagnostic Interview for Children and Adolescents-Revised (DICA-R), and measures of depressive symptomatology. Of 66 subjects (40 girls; mean age, 14.4 ± 2.2 years), 34 (51.5%) met DICA-R criteria for MDD at the initial postadmission assessment. Of these, only 8 (23.5%) met DICA-R criteria for MDD at any subsequent assessment. Similar reductions were found on other ratings of depression. In conclusion, MDD did not persist in this sample. The findings suggest a multigated assessment procedure should be employed before randomization in antidepressant clinical trials.


Key Words: Depressionadolescentsstudy design


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
A. L. Dunn and P. Weintraub
Exercise in the Prevention and Treatment of Adolescent Depression: A Promising but Little Researched Intervention
American Journal of Lifestyle Medicine, November 1, 2008; 2(6): 507 - 518.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Clinical Pharmacology